VMP 42016311000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Pentazocine 50mg capsules
BNF code 0407020T0AAAAAA
Virtual Therapeutic Moiety Pentazocine
Date identifier became valid 3 Jul 2023
Previous product identifier 322600003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Pentazocine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 3 (CD No Register Exempt Safe Custody)
Date of applicability 24 Nov 2014
Previous Controlled Drug information Schedule 3 (CD No Register)
Actual Medicinal Products
Pentazocine 50mg capsules (A A H Pharmaceuticals Ltd)
Pentazocine 50mg capsules (Accord-UK Ltd)
Pentazocine 50mg capsules (Medihealth (Northern) Ltd)
Pentazocine 50mg capsules (Sigma Pharmaceuticals Plc)
Pentazocine 50mg capsules (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Pentazocine 50mg capsules 100 capsule
Pentazocine 50mg capsules 28 capsule

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback